Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19
In: Chest, Jg. 164 (2023-12-01), Heft 6, S. 1531-1550
serialPeriodical
Zugriff:
Evidence increasingly shows that the risk of thrombotic complications in COVID-19 is associated with a hypercoagulable state. Several organizations have released guidelines for the management of COVID-19-related coagulopathy and prevention of VTE. However, an urgent need exists for practical guidance on the management of arterial thrombosis and thromboembolism in this setting.
Titel: |
Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19
|
---|---|
Autor/in / Beteiligte Person: | Potpara, Tatjana ; Angiolillo, Dominick J. ; Bikdeli, Behnood ; Capodanno, Davide ; Cole, Oana ; Yataco, Angel Coz ; Dan, Gheorghe-Andrei ; Harrison, Stephanie ; Iaccarino, Jonathan M. ; Moores, Lisa K. ; Ntaios, George ; Lip, Gregory Y.H. |
Zeitschrift: | Chest, Jg. 164 (2023-12-01), Heft 6, S. 1531-1550 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 0012-3692 (print) ; 1931-3543 (print) |
DOI: | 10.1016/j.chest.2023.06.032 |
Sonstiges: |
|